ERJ Podcast August 2017: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town, South Africa.
Supplementary Material
Subscribe to the ERJ Podcast via iTunes, SoundCloud or RSS
Download the August podcast August_2017
- Copyright ©ERS 2017